President Trump’s emphasis on putting America first and returning manufacturing jobs to the United States has clearly signaled that no industry is safe from his scrutiny and vitriolic criticism.

Regardless of one’s personal beliefs about the polarizing administration, there are solid moral and economic reasons the President placed a large target on the pharmaceutical industry’s back. The United States is an important market for major pharmaceutical companies, as its consumers pay the highest per capita drug prices in the world and account for the plurality of their revenues,